Bisdemethoxycurcumin Inhibits Hepatocellular Carcinoma Proliferation Through Akt Inactivation via CYLD-Mediated Deubiquitination

BACKGROUND: Bisdemethoxycurcumin (BDMC), a stable bioactive ingredient in curcuminoids, is associated with various antitumor functions, such as proliferation inhibition, metastasis suppression and apoptosis induction, in many cancer types. However, the mechanism of BDMC in hepatocellular carcinoma (...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Chengjiang, Liu, Kairui, Zhang, Sheng, Gao, Simin, Chen, Weirun, Li, Dateng, Huang, Youxing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2020
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062405/
https://www.ncbi.nlm.nih.gov/pubmed/32184568
http://dx.doi.org/10.2147/DDDT.S231814

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7062405/
https://www.ncbi.nlm.nih.gov/pubmed/32184568
http://dx.doi.org/10.2147/DDDT.S231814

Ejemplares similares